Report Detail
Global (United States, European Union and China) Diabetes Drug Therapy Market Research Report 2019-2025
- RnM3681923 |
- 19 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is not capable of producing sufficient insulin, it leads to an increase in blood glucose levels in the body. This condition is referred to as diabetes. Depending on the cause of development, it is divided into three types, which includes type 1 diabetes (body loses the capacity of producing sufficient insulin), type 2 diabetes (most common and body cells do not respond to insulin) and gestational diabetes (occurs in pregnant women). Among these, type 2 diabetes is the most common type and affects over 90% of the global diabetic patients.
In 2019, the market size of Diabetes Drug Therapy is 10000 million US$ and it will reach 21400 million US$ in 2025, growing at a CAGR of 10.0% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Diabetes Drug Therapy.
This report studies the global market size of Diabetes Drug Therapy, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Diabetes Drug Therapy sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abbott Laboratories
Mannkind Corporation
Bristol Myers Squibb
Medtronic
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline
Sanofi
Novo Nordisk
Novartis International AG
Market Segment by Product Type
Glucagon-like peptide-1 (GLP-1) agonist
Dipeptidyl-peptidase-4 (DPP-4) inhibitors
Sodium glucose co-transporter 2 (SGLT2) inhibitors
Insulin
Others
Market Segment by Application
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Impaired Glucose Tolerance and Impaired Fasting Glycaemia
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Diabetes Drug Therapy status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Diabetes Drug Therapy manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Diabetes Drug Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Diabetes Drug Therapy Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Glucagon-like peptide-1 (GLP-1) agonist
- 1.3.3 Dipeptidyl-peptidase-4 (DPP-4) inhibitors
- 1.3.4 Sodium glucose co-transporter 2 (SGLT2) inhibitors
- 1.3.5 Insulin
- 1.3.6 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Diabetes Drug Therapy Market Share by Application (2019-2025)
- 1.4.2 Type 1 Diabetes
- 1.4.3 Type 2 Diabetes
- 1.4.4 Gestational Diabetes
- 1.4.5 Impaired Glucose Tolerance and Impaired Fasting Glycaemia
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Diabetes Drug Therapy Market Size
- 2.1.1 Global Diabetes Drug Therapy Revenue 2014-2025
- 2.1.2 Global Diabetes Drug Therapy Sales 2014-2025
- 2.2 Diabetes Drug Therapy Growth Rate by Regions
- 2.2.1 Global Diabetes Drug Therapy Sales by Regions 2014-2019
- 2.2.2 Global Diabetes Drug Therapy Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Diabetes Drug Therapy Sales by Manufacturers
- 3.1.1 Diabetes Drug Therapy Sales by Manufacturers 2014-2019
- 3.1.2 Diabetes Drug Therapy Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Diabetes Drug Therapy Revenue by Manufacturers (2014-2019)
- 3.2.2 Diabetes Drug Therapy Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Diabetes Drug Therapy Market Concentration Ratio (CR5 and HHI)
- 3.3 Diabetes Drug Therapy Price by Manufacturers
- 3.4 Key Manufacturers Diabetes Drug Therapy Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Diabetes Drug Therapy Market
- 3.6 Key Manufacturers Diabetes Drug Therapy Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Glucagon-like peptide-1 (GLP-1) agonist Sales and Revenue (2014-2019)
- 4.1.2 Dipeptidyl-peptidase-4 (DPP-4) inhibitors Sales and Revenue (2014-2019)
- 4.1.3 Sodium glucose co-transporter 2 (SGLT2) inhibitors Sales and Revenue (2014-2019)
- 4.1.4 Insulin Sales and Revenue (2014-2019)
- 4.1.5 Others Sales and Revenue (2014-2019)
- 4.2 Global Diabetes Drug Therapy Sales Market Share by Type
- 4.3 Global Diabetes Drug Therapy Revenue Market Share by Type
- 4.4 Diabetes Drug Therapy Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Diabetes Drug Therapy Sales by Application
6 United States
- 6.1 United States Diabetes Drug Therapy Breakdown Data by Company
- 6.2 United States Diabetes Drug Therapy Breakdown Data by Type
- 6.3 United States Diabetes Drug Therapy Breakdown Data by Application
7 European Union
- 7.1 European Union Diabetes Drug Therapy Breakdown Data by Company
- 7.2 European Union Diabetes Drug Therapy Breakdown Data by Type
- 7.3 European Union Diabetes Drug Therapy Breakdown Data by Application
8 China
- 8.1 China Diabetes Drug Therapy Breakdown Data by Company
- 8.2 China Diabetes Drug Therapy Breakdown Data by Type
- 8.3 China Diabetes Drug Therapy Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Diabetes Drug Therapy Breakdown Data by Company
- 9.2 Rest of World Diabetes Drug Therapy Breakdown Data by Type
- 9.3 Rest of World Diabetes Drug Therapy Breakdown Data by Application
- 9.4 Rest of World Diabetes Drug Therapy Breakdown Data by Countries
- 9.4.1 Rest of World Diabetes Drug Therapy Sales by Countries
- 9.4.2 Rest of World Diabetes Drug Therapy Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Abbott Laboratories
- 10.1.1 Abbott Laboratories Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Diabetes Drug Therapy
- 10.1.4 Diabetes Drug Therapy Product Introduction
- 10.1.5 Abbott Laboratories Recent Development
- 10.2 Mannkind Corporation
- 10.2.1 Mannkind Corporation Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Diabetes Drug Therapy
- 10.2.4 Diabetes Drug Therapy Product Introduction
- 10.2.5 Mannkind Corporation Recent Development
- 10.3 Bristol Myers Squibb
- 10.3.1 Bristol Myers Squibb Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Diabetes Drug Therapy
- 10.3.4 Diabetes Drug Therapy Product Introduction
- 10.3.5 Bristol Myers Squibb Recent Development
- 10.4 Medtronic
- 10.4.1 Medtronic Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Diabetes Drug Therapy
- 10.4.4 Diabetes Drug Therapy Product Introduction
- 10.4.5 Medtronic Recent Development
- 10.5 AstraZeneca
- 10.5.1 AstraZeneca Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Diabetes Drug Therapy
- 10.5.4 Diabetes Drug Therapy Product Introduction
- 10.5.5 AstraZeneca Recent Development
- 10.6 Eli Lilly and Company
- 10.6.1 Eli Lilly and Company Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Diabetes Drug Therapy
- 10.6.4 Diabetes Drug Therapy Product Introduction
- 10.6.5 Eli Lilly and Company Recent Development
- 10.7 GlaxoSmithKline
- 10.7.1 GlaxoSmithKline Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Diabetes Drug Therapy
- 10.7.4 Diabetes Drug Therapy Product Introduction
- 10.7.5 GlaxoSmithKline Recent Development
- 10.8 Sanofi
- 10.8.1 Sanofi Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Diabetes Drug Therapy
- 10.8.4 Diabetes Drug Therapy Product Introduction
- 10.8.5 Sanofi Recent Development
- 10.9 Novo Nordisk
- 10.9.1 Novo Nordisk Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Diabetes Drug Therapy
- 10.9.4 Diabetes Drug Therapy Product Introduction
- 10.9.5 Novo Nordisk Recent Development
- 10.10 Novartis International AG
- 10.10.1 Novartis International AG Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Diabetes Drug Therapy
- 10.10.4 Diabetes Drug Therapy Product Introduction
- 10.10.5 Novartis International AG Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Diabetes Drug Therapy Sales Channels
- 11.2.2 Diabetes Drug Therapy Distributors
- 11.3 Diabetes Drug Therapy Customers
12 Market Forecast
- 12.1 Global Diabetes Drug Therapy Sales and Revenue Forecast 2019-2025
- 12.2 Global Diabetes Drug Therapy Sales Forecast by Type
- 12.3 Global Diabetes Drug Therapy Sales Forecast by Application
- 12.4 Diabetes Drug Therapy Forecast by Regions
- 12.4.1 Global Diabetes Drug Therapy Sales Forecast by Regions 2019-2025
- 12.4.2 Global Diabetes Drug Therapy Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Diabetes Drug Therapy. Industry analysis & Market Report on Diabetes Drug Therapy is a syndicated market report, published as Global (United States, European Union and China) Diabetes Drug Therapy Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Diabetes Drug Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
